Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG

NCT00251121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2012-02-09

No results posted yet for this study

Summary

Patients complaining of tachycardia but with a negative Holter ECG, are for a limited time period offered a simplified electrophysiological(EP) examination. By a full electrophysiological study(EP study)electrodes are introduced for pacing and sensing i all four heart chambers. Where as by the mini invasive EP study only one electrode is introduced to the right atrium. The simplified procedure represent a smaller risk of complications, requires less resources but should yield the same diagnoses in more than 90% of the cases. The study is a feasibility study to see if the procedure can discover arrythmias in a fairly unselected patient population.

Conditions

  • Pre-excitation Syndromes
  • Paroxysmal Tachycardia
  • Atrial Fibrillation
  • Atrial Flutter
  • Wolff-Parkinson-White Syndrome

Interventions

OTHER

Mini-invasive electrophysiological study

Transvenous pacing in right heart atrium

OTHER

Atrial pacing

Diagnostic pacing in right heart atrium in order to unmask reentry tachycardia

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER
  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Jan Hysing, MD. PhD. · Cardiologist at Medical Department Sykehuset Telemark

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00251121 on ClinicalTrials.gov